Detalhe da pesquisa
1.
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.
Cell
; 162(1): 146-59, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140595
2.
From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [89Zr]Zr-PSMA-DFO.
Molecules
; 29(1)2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38202768
3.
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Trends Genet
; 30(8): 326-39, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25017190
4.
Inferring primary tumor sites from mutation spectra: a meta-analysis of histology-specific aberrations in cancer-derived cell lines.
Hum Mol Genet
; 23(6): 1527-37, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24163242
5.
A framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Proc Natl Acad Sci U S A
; 109(42): 17034-9, 2012 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035247
6.
Blocking the angiopoietin-2-dependent integrin ß-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
JCI Insight
; 9(10)2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775153
7.
Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.
Nat Biotechnol
; 40(11): 1634-1643, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726091
8.
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
Mol Imaging Biol
; 24(1): 115-125, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370181
9.
An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients.
J Nucl Med
; 63(4): 573-583, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326129
10.
Genome-wide analysis of somatic noncoding mutation patterns in cancer.
Science
; 376(6589): eabg5601, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389777
11.
[18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer.
Mol Imaging Biol
; 23(2): 277-286, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33006028
12.
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology.
Nat Cancer
; 2(10): 1102-1112, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121878
13.
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival.
Cancer Res
; 81(15): 3971-3984, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099491
14.
Identification of cancer driver genes based on nucleotide context.
Nat Genet
; 52(2): 208-218, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015527
15.
An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application.
J Nucl Med
; 61(2): 202-209, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324713
16.
Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer.
J Nucl Med
; 61(5): 729-734, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628219
17.
Integrated molecular drivers coordinate biological and clinical states in melanoma.
Nat Genet
; 52(12): 1373-1383, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230298
18.
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.
Cell Rep
; 31(4): 107568, 2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348765
19.
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nat Med
; 26(7): 1147, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561875
20.
Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer.
EJNMMI Res
; 9(1): 66, 2019 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346821